At ASH 2025, Fulcrum presented promising data on a sickle cell pill and Incyte is pioneering a new way to treat myelofibrosis ...
Incyte's data bolster efforts to develop a new type of drug for myelofibrosis, and suggest it may be a replacement for Jakafi ...
A higher dose of the experimental pill for sickle cell disease showed more promise, Fulcrum said at the American Society of ...
Gilead and Arcellx reported promising data for their CAR-T therapy anito-cel at the annual American Society of Hematology ...
A new report looks at Chinese biotech innovation capturing the attention of pharmaceutical executives and investors worldwide ...